Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Agb
2. 1ejn
3. Schembl4328331
4. Wx293t
5. Schembl14524522
6. Bdbm16176
7. Wx-293t
8. Db03782
9. Q27094675
10. 3-(1-adamantyl)-1-[(4-carbamimidamidophenyl)methyl]urea
11. 3-adamantan-1-yl-1-[(4-carbamimidamidophenyl)methyl]urea
12. 1-(4-carbamimidamidobenzyl)-3-[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]dec-1-yl]urea
13. 282718-42-7
| Molecular Weight | 341.5 g/mol |
|---|---|
| Molecular Formula | C19H27N5O |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 341.22156050 g/mol |
| Monoisotopic Mass | 341.22156050 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea, including repackagers and relabelers. The FDA regulates n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea supplier is an individual or a company that provides n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea active pharmaceutical ingredient (API) or n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea finished formulations upon request. The n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea suppliers may include n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea API manufacturers, exporters, distributors and traders.
click here to find a list of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea DMF (Drug Master File) is a document detailing the whole manufacturing process of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea active pharmaceutical ingredient (API) in detail. Different forms of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea DMFs exist exist since differing nations have different regulations, such as n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea DMF submitted to regulatory agencies in the US is known as a USDMF. n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea USDMF includes data on n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea suppliers with USDMF on PharmaCompass.
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea GMP manufacturer or n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea GMP API supplier for your needs.
A n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea CoA (Certificate of Analysis) is a formal document that attests to n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea's compliance with n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea specifications and serves as a tool for batch-level quality control.
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea CoA mostly includes findings from lab analyses of a specific batch. For each n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea may be tested according to a variety of international standards, such as European Pharmacopoeia (n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea EP), n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea JP (Japanese Pharmacopeia) and the US Pharmacopoeia (n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea USP).
LOOKING FOR A SUPPLIER?
